By which route and into which veins should the Baxter Healthcare Ltd potassium chloride 0.15%, sodium chloride 0.18% and glucose 4% infusion product be administered?

The Baxter Healthcare Ltd potassium chloride 0.15%, sodium chloride 0.18% and glucose 4% infusion product should be infused slowly intravenously using sterile, non-pyrogenic equipment into a large peripheral or central vein, with central catheters outside the atrium or ventricle; hyperosmolar solutions are recommended for a large central vein.